Grabar Law Office Investigates Claims on Behalf of Shareholders of the Beauty Health Company (SKIN)

Philadelphia, Pennsylvania--(Newsfile Corp. - May 7, 2025) - Grabar Law Office is investigating whether the officers and directors of The Beauty Health Company (NASDAQ: SKIN) breached their fiduciary duties owed to the Company.

Current The Beauty Health Company (NASDAQ: SKIN) shareholders who have held the stock since on or before May 10, 2022, can seek corporate reforms, the return of funds spent defending litigation back to the company, and a court approved incentive award, at no cost to them. Learn more or join at: https://grabarlaw.com/the-latest/skin-shareholder-investigation/. Contact Joshua H. Grabar at jgrabar@grabarlaw.com, or call 267-507-6085.

WHY: As alleged in an underlying securities fraud class action complaint, The Beauty Health Company, via certain of its officers, made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company's business, operations, and prospects. Specifically, the Complaint alleges Defendants failed to disclose to investors: (1) that Syndeo 1.0 and 2.0 devices had issues leading to "frequent treatment interruptions;" (2) that, as a result, the Company incurred significant costs to develop enhancements; (3) that, despite the enhancements, providers continued to experience issues with the Syndeo devices; (4) that, as a result, the Company would no longer market Syndeo 1.0 and 2.0 devices and incur significant inventory write-downs; (5) that, as a result, the Company's profitability would be adversely impacted; and (6) that, as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

WHAT YOU CAN DO NOW: Current The Beauty Health Company shareholders who have held The Beauty Health Company shares since prior to May 10, 2022, can seek corporate reforms, the return of funds spent defending litigation back to the company, and a court approved incentive award, at no cost to them. If you would like to learn more about this matter, you are encouraged to visit https://grabarlaw.com/the-latest/skin-shareholder-investigation/, contact us at jgrabar@grabarlaw.com, or call 267-507-6085.

Attorney Advertising Disclaimer

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/251152